Get the Stockscreener App
2.47
5.00%
-0.13
Pre-market:
2.48
0.010
+0.40%
Alaunos Therapeutics Inc stock is traded at $2.47, with a volume of 88,023.
It is down -5.00% in the last 24 hours and down -51.28% over the past month.
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations. It has a single reportable and operating segment related to biopharmaceutical research and development.
See More
Previous Close:
$2.60
Open:
$2.61
24h Volume:
88,023
Relative Volume:
2.17
Market Cap:
$4.05M
Revenue:
-
Net Income/Loss:
$-36.46M
P/E Ratio:
-1.0292
EPS:
-2.4
Net Cash Flow:
$-30.20M
1W Performance:
-9.85%
1M Performance:
-51.28%
6M Performance:
+52.00%
1Y Performance:
-7.86%
1-Day Range:
$2.43
$2.79
1-Week Range:
$2.43
$3.1503
52-Week Range:
$1.3137
$6.20
Alaunos Therapeutics Inc Stock (TCRT) Company Profile
Name
Alaunos Therapeutics Inc
Sector
Industry
Phone
(346) 355-4099
Address
2617 BISSONNET ST, HOUSTON
Compare TCRT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TCRT
Alaunos Therapeutics Inc
|
2.47 | 4.66M | 0 | -36.46M | -30.20M | -2.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Alaunos Therapeutics Inc Stock (TCRT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-04-22 | Resumed | Wells Fargo | Overweight |
Alaunos Therapeutics Inc Stock (TCRT) Latest News
Why Alaunos Therapeutics Inc. stock attracts strong analyst attentionSwing Reversal Forecast Based on Patterns - Newser
Real time social sentiment graph for Alaunos Therapeutics Inc.Free Fundamental + Technical Hybrid Stock Tips - Newser
Using data models to predict Alaunos Therapeutics Inc. stock movementValue Holding Return Summary With Outlook - Newser
Analyzing recovery setups for Alaunos Therapeutics Inc. investorsFree Access to Smart Investment Tips - Newser
Is Alaunos Therapeutics Inc. trending in predictive chart modelsTrading Volume Spike and Reversal Analysis - Newser
Risk vs reward if holding onto Alaunos Therapeutics Inc.Free Daily Chart Pattern Stock Forecast - Newser
Volatility clustering patterns for Alaunos Therapeutics Inc.Momentum Trading Guide with Safety Limits - Newser
What moving averages say about Alaunos Therapeutics Inc.Equity Signal Recap With Long-Term Summary - Newser
What technical models suggest about Alaunos Therapeutics Inc.’s comebackFree Fast Entry High Potential Stock Alerts - Newser
Custom watchlist performance reports with Alaunos Therapeutics Inc.Machine Learning Stock Movement Detector - Newser
Using flow based indicators on Alaunos Therapeutics Inc.Real-Time Investment Picks with Accuracy - Newser
Detecting support and resistance levels for Alaunos Therapeutics Inc.Real-Time AI Sentiment and Price Forecast - Newser
Is Alaunos Therapeutics Inc. forming a reversal patternMarket Correction Proof Stock Screening Analysis - Newser
What recovery options are there for Alaunos Therapeutics Inc.Weekly Stock Market Strategy Summary - Newser
How to use a screener to detect Alaunos Therapeutics Inc. breakoutsReal-Time Investment Signal Forecast with AI - Newser
Is now a turning point for Alaunos Therapeutics Inc.Weekly Trend Watch with Market Signals - Newser
Using Bollinger Bands to evaluate Alaunos Therapeutics Inc.Free Pattern Breakout Entry Stock Forecast - Newser
Is this a good reentry point in Alaunos Therapeutics Inc.Entry Opportunity Screener with Confirmation - Newser
Does Alaunos Therapeutics Inc. stock pay reliable dividendsIntraday Signal Forecast for Fast Traders - Newser
Identifying reversal signals in Alaunos Therapeutics Inc.Loss Limitation Strategy Based on Analysis - Newser
Sector ETF performance correlation with Alaunos Therapeutics Inc.Free High Yield Stocks With Buy Confirmation - Newser
Intraday pattern recognizer results for Alaunos Therapeutics Inc.AI Risk Optimized Trade Forecast Planner - Newser
How to build a dashboard for Alaunos Therapeutics Inc. stockCapital Growth Plan for New Investors - Newser
What are Alaunos Therapeutics Inc. company’s key revenue driversExponential wealth increase - Jammu Links News
Is it the right time to buy Alaunos Therapeutics Inc. stockAchieve breakthrough results with expert guidance - Jammu Links News
What institutional investors are buying Alaunos Therapeutics Inc. stockAccelerate your capital gains today - Jammu Links News
How volatile is Alaunos Therapeutics Inc. stock compared to the marketProven strategies for superior portfolio growth - Jammu Links News
Alaunos Therapeutics Inc. Stock Analysis and ForecastUnprecedented profit potential - Jammu Links News
What drives Alaunos Therapeutics Inc. stock priceBreakout portfolio performance - Jammu Links News
Alaunos Therapeutics Inc Stock (TCRT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.24%
3.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):